<html>
<head>PUBMED IDs for STAM2</head>
<body bgcolor='#C5F0F2'><h1>STAM2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10899310/'>STAM2, a new member of the STAM family, binding to the Janus kinases.</a> July 19  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10993906/'>Identification of a novel immunoreceptor tyrosine-based activation motif-containing molecule, STAM2, by mass spectrometry and its involvement in growth factor and cytokine receptor signaling pathways.</a> September 20  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/15640163/'>Hrs, a mammalian master molecule in vesicular transport and protein sorting, suppresses the degradation of ESCRT proteins signal transducing adaptor molecule 1 and 2.</a> January 11  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17452457/'>Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo.</a> April 25  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/25092874/'>RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development.</a> October 23  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25953263/'>Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted &quot;hsa-miR-2278&quot; as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.</a> January 27  2015<br></body></html>
